Mylotarg (gemtuzumab ozogamicin)

pCPA File Number: 21180
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Myeloid Leukemia (AML)
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
PC0190-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: